A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

Clinical trial NCT00328497 · COMPLETED

Trial details

NCT number: NCT00328497
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Tumor

Start date: 2006-05-01
Primary completion: 2008-12-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.